Recent Visitors
Jessica Pruszynski PhDJessica Pruszynski PhD
Karen-Sue B. Carlson MD, PhDKaren-Sue B. Carlson MD, PhD
Joseph J. Budovec MDJoseph J. Budovec MD
Andrea Morrison MDAndrea Morrison MD
Matthew Myrvik PhDMatthew Myrvik PhD

James B. Gosset MD Online Profile

James B. Gosset MD

Assistant Professor
Medical College of Wisconsin
Department: Medicine
Division: Cardiology
Program: Clinical


Publications

  • Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. (Kipshidze N, Chekanov V, Chawla P, Shankar LR, Gosset JB, Kumar K, Hammen D, Gordon J, Keelan MH) Tex Heart Inst J 2000;27(2):196-200 PMID 10928508

    • Grants and Awards

  • A Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy and Safety of 4 Administrations of XRP0038/NV1FGF, 4 mg at 2-Week Intervals on Amputation or Any Death in Critical Limb Ischemia Patients with Skin Lesions (#9304438 01/29/2009 - 09/25/2012) Sponsor: Sanofi-Aventis U.S. Inc.
  • A randomized, double-blinded, placebo-controlled, phase IIa dose-ranging study to assess the safety, pharmacokinetics, and tolerability of multiple doses of sodium nitrite in patients with peripheral arterial disease (PAD) - SONIC (#9305683 04/23/2012 - 01/22/2016) Sponsor: TheraVasc, Inc
  • A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Ixmyelocel-T in Subjects with Critical Limb Ischemia and No Otions for Rvascularization PRO#:55-1009-1 (#9305991 01/08/2013 - 01/07/2016) Sponsor: Aastrom Biosciences, Inc.